Target intelligence / Profile preview

Protease-activated receptor 2-Transient receptor potential vanilloid 4 signaling complex (PAR2-TRPV4)

Target
PAR2-TRPV4
Molecular classification
G protein-coupled receptor, Ion channel, Protein complex
01

Overview

The Protease-activated receptor 2-Transient receptor potential vanilloid 4 (PAR2-TRPV4) coupling is a specialized signaling mechanism where the activation of the G protein-coupled receptor PAR2 sensitizes the TRPV4 ion channel. This interaction typically occurs on the plasma membrane of nociceptive neurons and epithelial cells, facilitating the transduction of inflammatory stimuli into electrical signals. Proteases such as tryptase or trypsin cleave the N-terminus of PAR2, triggering a signaling cascade involving phospholipase C (PLC) and protein kinases (PKA/PKC) that phosphorylate and activate TRPV4 (Poole et al., 2013, J Biol Chem). This synergy results in enhanced calcium influx and the release of pro-inflammatory neuropeptides like Substance P and Calcitonin Gene-Related Peptide (CGRP). The PAR2-TRPV4 axis is a significant therapeutic target for treating chronic inflammatory conditions, visceral hypersensitivity in irritable bowel syndrome, and various forms of pruritus (Cenac et al., 2007, J Clin Invest). Pharmacological intervention usually involves small molecule antagonists of either PAR2 or TRPV4 to disrupt this pro-nociceptive signaling pathway.

Other names
PAR2-TRPV4 axisPAR2-TRPV4 signaling pathwayF2RL1-TRPV4 interactionPAR2-TRPV4 functional coupling
02

Mechanism of action

PAR2 activation by proteases triggers intracellular signaling (PLC/PKC/PKA) that sensitizes TRPV4, leading to increased calcium influx and neuronal excitation.

03

Biological functions

Signal transductionNociceptionCalcium signalingInflammatory responseNeurogenic inflammation
04

Disease associations

InflammationChronic painIrritable bowel syndromePancreatitisPruritusArthritis
05

Safety considerations

Thermoregulation disruptionVascular permeability changesPulmonary edema riskBladder dysfunctionOsmotic balance disruption
06

Interacting drugs

HC-067047

5 more in the full profile.

07

Biomarkers

Transient receptor potential vanilloid 4 (TRPV4) expression levelsProtease-activated receptor 2 (PAR2) expression levelsCalcitonin gene-related peptide (CGRP) releaseSubstance P releaseIntracellular calcium ([Ca2+]i) mobilization

Beyond the preview

Go deeper on Protease-activated receptor 2-Transient receptor potential vanilloid 4 signaling complex (PAR2-TRPV4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protease-activated receptor 2-Transient receptor potential vanilloid 4 signaling complex (PAR2-TRPV4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call